Home
About
Overview
Sharing Data
ORCID
Help
History (6)
An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma.
Association of Advance Care Planning Visits With Intensity of Health Care for Medicare Beneficiaries With Serious Illness at the End of Life.
Direct visualization of myosin-binding protein C bridging myosin and actin filaments in intact muscle.
FGFR inhibitors in urothelial cancer: Contextualizing THOR within the new treatment landscape.
Microglia heterogeneity in health and disease.
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Microglia heterogeneity in health and disease.
Dadwal S, Heneka MT. Microglia heterogeneity in health and disease. FEBS Open Bio. 2024 02; 14(2):217-229.
View in:
PubMed
subject areas
Brain
Homeostasis
Humans
Inflammation
Microglia
Neurodegenerative Diseases
authors with profiles
Michael Thomas Heneka MD